Breaking Canadian GLP-1 news
GLP-1 News — Page 4
Drug approvals, price changes, generic timelines, and clinical trial results affecting GLP-1 medication costs in Canada.
Where are you in your GLP-1 journey?
Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.
Health Canada Notice: Seven More Generic Semaglutide Files in Queue
After Apotex became Canada's second generic semaglutide approval on May 1, seven additional generic semaglutide submissions remain under review at Health Canada.
Rexall, Shoppers Expect Generic Semaglutide Shipments This Week
Rexall expects a generic semaglutide shipment by week's end and Shoppers Drug Mart says inventory is arriving at distribution centres and select stores.
Novo Nordisk Savings Card Routes Ozempic Discount Through Rexall
Novo Nordisk Canada's reduced Ozempic price for uninsured patients launches via a Savings Card applied automatically at Novo Nordisk Care Rx by Rexall, excluding Quebec.
Health Canada Hit 180-Day Generic Target 84% of Time in FY25
Health Canada met its 180-day generic review target 84% of the time in fiscal 2024-25 as 500+ submissions sit under review, including seven semaglutide files.
Novo Nordisk Cites 9,650-Patient SOUL Trial Behind Rybelsus Nod
Novo Nordisk's Rybelsus MACE indication in Canada is backed by the 9,650-patient SOUL trial, with President Vince Lamanna calling it an important milestone.
CDA Benchmarks Mounjaro to Ozempic's $228 List Price in Canada
Canada's Drug Agency suggests public plans pay no more for 5 mg Mounjaro than the $228 list price of 1 mg Ozempic, with 25-49% discounts at higher doses.
Obesity Canada Cites $27.6B Untreated Cost in Coverage Pivot
Obesity Canada's Sockalingam ties the $27.6B 2023 untreated-obesity cost and sub-20% private-plan coverage to Canada's G7-first generic semaglutide approval.
Saskatchewan Blue Cross: Generic Semaglutide Doesn't Change Plan Rules
Saskatchewan Blue Cross says coverage rules for semaglutide are not changing after Health Canada's G7-first generic approval, though out-of-pocket costs may fall.
Apotex 2 mg and 4 mg Pens Set to Hit Alberta Shelves 'Any Day'
Apotex told CBC its 2 mg and 4 mg pre-filled generic semaglutide pens will reach Alberta pharmacies 'any day', with stock orders starting this week.
Alberta Pharmacies Begin Ordering Generic Semaglutide This Week
Calgary pharmacist Wessam Sakr was notified he could start ordering generic semaglutide this week, with Apotex pens expected on Alberta shelves any day.
Walk-In Maps Patent Timeline Behind Canada's G7-First Generic
Walk-In Clinic details the 2020 patent lapse, January 2026 data exclusivity end, and March 2026 formulation patent expiry that opened Canada's generic semaglutide path.
CDA Mounjaro Math: Lilly's $300 Floor Meets a 25-49% Discount Ask
Canada's Drug Agency wants 25-49% off higher-dose Mounjaro list prices, even after Eli Lilly's December cut set 2.5 and 5 mg at $300 for four weeks.
BMJ: Canada Is Only the Second Country to Clear Generic Semaglutide
BMJ reports Canada is only the second country in the world to approve a generic semaglutide, with two products cleared and seven more under Health Canada review.
Health Canada Details DIN Checks, CBSA Role in GLP-1 Advisory
Health Canada's January 21 advisory tells buyers to verify GLP-1 drugs via eight-digit DIN and Drug Product Database, and flags CBSA cooperation on shipments.
Endor Health Lists Sandoz, Apotex, Teva, Taro, Aspen in Queue
Endor Health names Sandoz, Apotex, Teva, Taro and Aspen among nine generic semaglutide submissions before Health Canada, citing a 180-day target review.
CMA Explainer Maps Post-Approval Access Path for Canadians
CMA's patient explainer details prescription rules, provincial coverage limits, and what Canadians should expect as generic semaglutide enters pharmacies.
TrumpRx GLP-1 Prices Land at US$350, Above Canadian List Prices
TrumpRx will start GLP-1 sales at US$350 monthly dropping to US$245, while Canadian list prices for Ozempic sit near $228 and Mounjaro $300–$540.
Dr. Reddy's Generic Semaglutide Reached Canadian Pharmacies May 15
Dr. Reddy's generic semaglutide became available in Canada on May 15, 2026, with Shoppers Drug Mart and Rexall confirming inventory arriving at distribution centres.
Where Generic Semaglutide Is Made: Apotex, Dr. Reddy's Detail Sites
Apotex confirms its generic semaglutide injectors will be made in India by a partner with sterile fill capacity, while Dr. Reddy's lists India, UK and Mexico sites.
Insurers Detail How Generic Semaglutide Will Flow Through Plans
Canadian insurers including iA, Beneva, Sun Life and Desjardins outline how generic semaglutide will be reimbursed, with claims paid jumping to $77M in 2024.
Looking for current pharmacy prices?
Compare GLP-1 prices across Canada